As shown in Figure 5C, the expression of CXCL10 in sensitive tumor tissues is significantly up-regulated at different time points of treatment compared with resistant tumor tissues (Wilcoxon signed-rank test, *** P < 0.001). This evidence concerns the gene CXCL10 and neoplasm.